Carolyn Hoskins Kruse, Founder

Experience:
Sterling Winthrop Pharmaceutical Research Division, (now Sanofi Synthelabo) As a Project Director, Carolyn was responsible for defining global development strategies for drugs in a variety of therapeutic areas including cardiovascular, endocrine and antioxidant projects.
SmithKline Beecham Pharmaceuticals in US and international regulatory affairs and medicinal chemistry. During three years working in the UK, she was responsible for completing submissions to the UK MCA, the Irish NDAB and the EU CPMP including nine CTX applications and three Product License applications. As a Research Chemist at SB, Carolyn was the senior Test Tubesauthor of six and co-author of six research papers that were published in peer reviewed scientific journals. Therapeutic areas included:
  • New vaccines
  • Genetically engineered products
  • Antimalarials
  • Analgesics
  • Hematinics
  • Psychotropics
  • Drugs for osteoporosis
  • Agents to treat cardiovascular diseases

Education:
Massachusetts Institute of Technology: Cambridge, MA - M.S. in Organic Chemistry, H.E.
Trinity College: Hartford, CT - B.S. in Chemistry with
Additional Studies: Christ Church College, Oxford University, Oxford, England; University of Pennsylvania, Business Program Wharton Evening School